When you dispense the amount of meds that OCR does daily, it's not hard to see how you can continue to profit. Remember that margins on generics are higher than brand and once again, from a volume standpoint, think about the brand to generic releases quarterly and you can see how they can profit. Take also into consideration the flu season we are having and wait and see how their 4th quarter results show up. I think people will like what they see, but it is only window dressing. This company is poorly managed with "yes men and women" afraid to use the bathroom without fear of getting fired. The best thing that could happen to this company is Joel retires and sells off to Walgreens because I still don't believe he'll ever let someone else run "his" company..